FCA
IFRX icon

FinTrust Capital Advisors’s InflaRx IFRX Stock Holding History

FinTrust Capital Advisors’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed – – 1259
2022
Q1 		$0 Hold
100
– – ﹤0.01% 1253
2021
Q4 		$0 Buy
+100
New +$402 ﹤0.01% 1221

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

FinTrust Capital Advisors's IFRX Position: Q2 2022 in Review

FinTrust Capital Advisors sold out of InflaRx (IFRX) in Q2 2022, closing a stake of 100 shares.

FinTrust Capital Advisors first reported a position in IFRX in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 27 funds tracked by Wall St. Rank hold IFRX as of Q2 2022.

  • FinTrust Capital Advisors reported no remaining InflaRx position as of Q2 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 100 InflaRx shares in Q2 2022.
  • FinTrust Capital Advisors first reported a position in InflaRx in Q4 2021 and held it in 2 quarters.
  • FinTrust Capital Advisors's InflaRx position peaked at $0 in Q1 2022.
  • 27 funds tracked by Wall St. Rank held InflaRx as of Q2 2022.

Based on FinTrust Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.